Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
The drug Gleevec is well known not only for its effectiveness against leukemia. A similar drug might be able to tame some brain cancers, new research from Columbia University Medical Center has shown.
Columbia experts worked together to offer an innovative option to a pregnant woman needing radiation therapy for a fast-growing brain tumor.
With an HHMI fellowship, Columbia medical student Eli Sayegh is taking a year off from school to research a new theory about brain cancer.
A study has found 18 new genes that drive an aggressive form of brain cancer, doubling the number of known driver genes of glioblastoma.